TI
APTO

Telemetry Investments’s Aptose Biosciences, Inc. APTO Stock Holding History

Telemetry Investments’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$58K Buy
+222
New +$59.6K 0.09% 97

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $733M AUM 11.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Telemetry Investments's APTO Position: Q4 2022 in Review

Telemetry Investments opened a new position in Aptose Biosciences, Inc. (APTO) in Q4 2022: 222 shares worth $58K. The stake represents 0.09% of the portfolio and ranks #97 among its holdings.

47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

  • Telemetry Investments held 222 shares of Aptose Biosciences, Inc. worth $58K as of Q4 2022.
  • Aptose Biosciences, Inc. was a new Telemetry Investments position in Q4 2022.
  • Aptose Biosciences, Inc. made up 0.09% of Telemetry Investments's portfolio in Q4 2022, its #97 holding.
  • 47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.